Hangzhou Biotest BiotechLtd Balance Sheet Health
Financial Health criteria checks 6/6
Hangzhou Biotest BiotechLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥522.4K, which brings its debt-to-equity ratio to 0.02%. Its total assets and total liabilities are CN¥2.5B and CN¥152.7M respectively. Hangzhou Biotest BiotechLtd's EBIT is CN¥36.9M making its interest coverage ratio -0.5. It has cash and short-term investments of CN¥1.7B.
Key information
0.02%
Debt to equity ratio
CN¥522.44k
Debt
| Interest coverage ratio | -0.5x |
| Cash | CN¥1.67b |
| Equity | CN¥2.37b |
| Total liabilities | CN¥152.66m |
| Total assets | CN¥2.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688767's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥141.0M).
Long Term Liabilities: 688767's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥11.7M).
Debt to Equity History and Analysis
Debt Level: 688767 has more cash than its total debt.
Reducing Debt: 688767's debt to equity ratio has reduced from 23.3% to 0.02% over the past 5 years.
Debt Coverage: 688767's debt is well covered by operating cash flow (46517.8%).
Interest Coverage: 688767 earns more interest than it pays, so coverage of interest payments is not a concern.